To evaluate the clinical importance of RNF19A in BC progression, the correlation between BARD1/ RNF19A expression levels and clinical features was analyzed through human BBC tissue microarray (TMA) with 140 specimens, containing 46 pairs of matched breast tumor tissue and corresponding adjacent non-tumor breast tissue samples (Supplementary Table 1). The gene discussed is BARD1; the disease is neoplasm.